Početna › Dijabetes tipa 2 › Kalifornija
Kliničke studije za Dijabetes tipa 2 u državi Kalifornija
67 studija za Dijabetes tipa 2 traži sudionike na lokacijama u državi Kalifornija.
Gradovi u državi Kalifornija
- San Diego17 studija
- Los Angeles16 studija
- Long Beach11 studija
- Concord10 studija
- Sacramento9 studija
- Simi Valley8 studija
- El Cajon7 studija
- Mountain View7 studija
- Santa Clarita6 studija
- Escondido6 studija
- Chula Vista6 studija
- Pomona6 studija
- Roseville5 studija
- Ontario4 studija
- Westminster4 studija
- West Covina4 studija
- Torrance4 studija
- Lancaster4 studija
- Santa Monica4 studija
- San Bernardino4 studija
- Huntington Beach4 studija
- San Francisco3 studija
- Santa Barbara3 studija
- South Gate3 studija
- Carson3 studija
- Tustin3 studija
Službeni tekst studije (engleski)
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
- San Diego State University, San Diego
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 18 do 64 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05279729Efficacy of Using Mobile Health Applications for Health
- San Diego State University, San Diego
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 18 do 64 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05589155A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Thrive Clinical Research Group, Glendora
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07783802Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
- Ark Clinical Research, Fountain Valley
- Thrive Clinical Research Group, Glendora
- Scripps Whittier Diabetes Inst, La Jolla
- i još 5
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07817251EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- National Heart Institute, Beverly Hills
- Hope Clinical Research, Canoga Park
- John Muir Physician Network Clinical Research Center, Concord
- i još 11
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07064473A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- San Fernando Valley Health, Canoga Park
- John Muir Physician Network Clinical Research Center, Concord
- Neighborhood Healthcare - Escondido, Escondido
- i još 9
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07754461A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Cardiovascular Research Foundation of Southern California, Beverly Hills
- Amicis Research: Beverly Hills, Beverly Hills
- Valiance Clinical Research - Canoga Park, Canoga Park
- i još 21
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 55 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT06112418Using Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes
- Stanford University, Stanford
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT06836479A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- San Fernando Valley Health Institute, Canoga Park
- Headlands Research California, LLC, Escondido
- ImmuniMet, LLC, Modesto
- i još 4
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07595549A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Escondido
- Research Site, Lincoln
- Research Site, Walnut Creek
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07776509A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- San Fernando Valley Health Institute, Canoga Park
- AMCR Institute, Escondido
- NorCal Medical Research, Inc, Greenbrae
- i još 6
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07282600A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Bakersfield
- Research Site, Gardena
- Research Site, Lincoln
- i još 2
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07784270A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Banning
- AURORA-2 Clinical Site, Chula Vista
- AURORA-2 Clinical Site, Covina
- i još 6
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 16. ruj 2026. · NCT07743450A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
- Research Site, Glendale
U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
Od 18 do 55 godina · Oba spola · Ažurirano 16. ruj 2026. · NCT07723833A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus
- Clinical Trial Site, Chula Vista
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 16. ruj 2026. · NCT07465224A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- Core Healthcare Group, Cerritos
- Ark Clinical Research - Long Beach, Long Beach
- Flourish Research - Walnut Creek - PPDS, Walnut Creek
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 15. ruj 2026. · NCT07340320A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Orange County Research Center, Lake Forest
- Ark Clinical Research, Long Beach
- Catalina Research Institute, LLC, Montclair
- i još 3
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT07351058Pregnancy and Postpartum Breastfeeding Support for Patients With Gestational Diabetes
- UC Davis Medical Center, Sacramento
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT07176793A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Wolverine Clinical Trials, Santa Ana
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 14. ruj 2026. · NCT06897475A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
- First Valley Medical Group, Lancaster
- Torrance Clinical Research Institute, Inc., Lomita
- Ark Clinical Research, Long Beach
- i još 3
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 11. ruj 2026. · NCT07415954Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- AME Clinical Research, Huntington Beach
- Amicis Research Center, Northridge
- FOMAT - Vista del Mar Medical Group, Oxnard
- i još 6
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 11. ruj 2026. · NCT07271186A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- Ark Clinical Research, Fountain Valley
- Ark Clinical Research, Long Beach
- Los Angeles Institute for Metabolic Research, Los Angeles
- i još 1
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 11. ruj 2026. · NCT07668388A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Covina
- Research Site, Encinitas
- Research Site, Garden Grove
- i još 4
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT07662213Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Ark Clinical Research - Fountain Valley, Fountain Valley
- Velocity Clinical Research, Huntington Park, Huntington Park
- Velocity Clinical Research - Gardena, La Mesa
- i još 4
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT07296484Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- San Fernando Valley Health Institute, Canoga Park
- Core Healthcare Group, Cerritos
- Velocity Clinical Research Chula Vista, Chula Vista
- i još 1
U tijeku regrutacijaFaza 3
Od 18 do 99 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT07684144A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Research Site, Concord
- Research Site, Sacramento
- Research Site, Victorville
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 2. ruj 2026. · NCT07662135AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- First Valley Medical Group, Lancaster
- Headlands Research CTR Lincoln, Lincoln
- Torrance Clin Res Inst, Inc., Lomita
- i još 6
U tijeku regrutacijaFaza 3
Od 45 godina i više · Oba spola · Ažurirano 1. ruj 2026. · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Bakersfield
- Research Site, Los Angeles
- Research Site, Ontario
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 31. kol 2026. · NCT07662109A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Lomita
- Research Site, Los Alamitos
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 31. kol 2026. · NCT07662044A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
- Research Site, Lincoln
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 25. kol 2026. · NCT07606066A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
- Research Site, Glendale
U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
Od 18 do 75 godina · Oba spola · Ažurirano 12. kol 2026. · NCT07024823Food Insecurity Reduction & Strategy Team
- Stanford Medicine, Palo Alto
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 11. kol 2026. · NCT06329375A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Division of Endocrinology, Diabetes, and Metabolism, Los Angeles
- UCLA Mattel Children's Hospital, Los Angeles
- University of California, San Francisco, San Francisco
U tijeku regrutacijaFaza 3
Od 10 do 17 godina · Oba spola · Ažurirano 7. kol 2026. · NCT06739122Safer Aging With Diabetes Monitoring
- Kaiser Permanente Sacramento, Sacramento
U tijeku regrutacija
Od 75 godina i više · Oba spola · Ažurirano 4. kol 2026. · NCT06296485A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
- Research Site, Sacramento
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 4. kol 2026. · NCT07664553Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
- University of Southern California, Los Angeles
- Sansum Diabetes Research Institute, Santa Barbara
U tijeku regrutacija
Od 14 do 75 godina · Oba spola · Ažurirano 3. kol 2026. · NCT07579702A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus
- Orange County Research Center, Lake Forest
U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
Od 18 do 75 godina · Oba spola · Ažurirano 3. kol 2026. · NCT07590193Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
- University of Southern California, Los Angeles
- HOAG, Newport Beach
- Sansum Diabetes Research Institute, Santa Barbara
- i još 1
U tijeku regrutacija
Od 18 do 75 godina · Oba spola · Ažurirano 3. kol 2026. · NCT07521475Time Restricted Eating in Patients With Microalbuminuria
- Altman Clinical and Translational Research Institute, La Jolla
U tijeku regrutacijaFaza 1
Od 18 do 75 godina · Oba spola · Ažurirano 14. srp 2026. · NCT06884059CGM for Management of Type 2 Diabetes in Pregnancy
- University of California at San Diego, San Diego
U tijeku regrutacija
Od 18 do 50 godina · Žene · Ažurirano 29. lip 2026. · NCT06628453Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.